- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Vivexia
Vivexia is listed as a small business research supplier in the Scientist.com network, with 2 sites in 1 country and 1 service area.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small business
Antibodies
- Polyclonal/Monoclonal Antibody Production Generate polyclonal or monoclonal antibodies in a range of animal species, over-express antibodies in cultured cells.
Biomarkers
- Antimicrobial Effectiveness Testing Measure the efficacy of anti-microbial preservatives added to a product.
Disease Models
- Bacterial Infection Models Measure therapeutic endpoints in animal models of bacterial infection.
- Infectious Disease Models Test therapeutic efficacy of drug candidate in infectious disease model.
- Respiratory Models Test therapeutic efficacy of drug candidate in respiratory disease model.
Effectiveness
- Antimicrobial Pharmacodynamics Ascertain the effectiveness of an antimicrobial compound and test levels of antibiotic resistance against specific bacterial pathogens.
- Minimum Bactericidal Concentration (MBC) Test Assess the bactericidal activity of a test compound.
Food Safety & Regulations
- Anaerobic Plate Count Determine the total anaerobic bacteria present in a food or contact-surface sample.
General in vivo Toxicology
- General Toxicology Use in vivo models to assess acute and sub-acute toxicity as well as chronic and sub-chronic toxicity.
In Vitro Assays
- Microbiology Study microbes and their role in human health.
In Vivo Pharmacokinetics
- Pharmacokinetic (PK) Screening - Mouse Run pharmacokinetic studies in mice that measure a drug's absorption, distribution, metabolism and excretion.
- Pharmacokinetic (PK) Screening - Rat Run pharmacokinetic studies in rats that measure a drug's absorption, distribution, metabolism and excretion.
Show all 15 services
Model Development
- Standard Models Create new animal disease models or modify existing models to study specific diseases, side-effects or symptoms.
Other Specialty Toxicology
- Microdilution Testing Simultaneously quantify the susceptibility of a microbial species or strain to multiple anti-microbial agents.
Testing Services
- CLSI M26-A: Minimum Bactericidal Concentration (MBC) Determine the lowest concentration of an antimicrobial agent that is lethal to the target bacteria in vitro.
Service areas:
Where it operates
Sites by country, with the cities in each.
-
France 2 sites
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
Vivexia is a privately-held company headquartered in Dijon (FRANCE) and specialized in the evaluation of the efficacy of anti-infectious drug candidates. We are developing a wide range of infectious models that are suited to both preclinical and phase IV studies. Our unrivalled expertise and the main innovative aspect of our technology are based on predictive performance and the humanization of the disease and its treatment. While already offering in-vivo pulmonary infection models, we keep on developing more innovative disease models in order to satisfy our clients’ enquiries. Vivexia...
Show the full description
Vivexia is a privately-held company headquartered in Dijon (FRANCE) and specialized in the evaluation of the efficacy of anti-infectious drug candidates. We are developing a wide range of infectious models that are suited to both preclinical and phase IV studies.
Our unrivalled expertise and the main innovative aspect of our technology are based on predictive performance and the humanization of the disease and its treatment. While already offering in-vivo pulmonary infection models, we keep on developing more innovative disease models in order to satisfy our clients’ enquiries.
Vivexia offers an extensive experience in drug testing in models of bacterial infections with a special focus on model of pulmonary infections. We can provide high expertise in the field of anti-infectious therapies and in-vivo pharmacodynamics studies in order to evaluate the efficacy of novel anti-infectious therapies. We are also committed to propose new strategies to prevent the development of resistance and limit the virulence of pathogens.
- Website
- www.vivexia.fr
Work with Vivexia on Scientist.com
For prices, more details, or to contact Vivexia, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.